Cyberonics Announces 2007 Lazard Capital Markets Fourth Annual Healthcare Conference Presentation and the 19th Annual Piper Jaffray Healthcare Conference Presentation

HOUSTON, Nov. 8 Cyberonics, Inc. (Nasdaq: CYBX)today announced that Dan Moore, Cyberonics' President and Chief ExecutiveOfficer, will present at the 2007 Lazard Capital Markets Fourth AnnualHealthcare Conference at the Palace Hotel in New York City on Tuesday,November 27, 2007 at 10:30 AM EST. Presentation slides will be availableon-line at http://www.cyberonics.com by 9:00 AM EST on Tuesday, November 27,2007. Lazard Capital Markets will host a webcast of the presentation live andby replay at http://www.wsw.com/webcast/lz4/cybx. The presentation can also beaccessed at http://www.cyberonics.com by clicking on the link for thiswebcast. Access to the webcast is not password protected.

Mr. Moore will also present at the 19th Annual Piper Jaffray HealthcareConference at the Pierre Hotel in New York City on Wednesday, November 28,2007 at 9:30 AM. Presentation slides will be available on-line athttp://www.cyberonics.com by 9:00 AM EST on Tuesday, November 27, 2007. PiperJaffray will host a webcast of the presentation live and by replay athttp://www.piperjaffray.com/conferences. The presentation can also be accessedat http://www.cyberonics.com by clicking on the link for this webcast. Accessto the webcast is not password protected.

ABOUT VNS THERAPY AND CYBERONICS

Information on Cyberonics, Inc. and VNS Therapy(TM) is available athttp://www.cyberonics.com and http://www.vnstherapy.com.CONTACT INFORMATION: Greg Browne, CFO Cyberonics, Inc. 100 Cyberonics Blvd. Houston, TX 77058 Main: (281) 228-7262 Fax: (281) 218-9332 [email protected]

SOURCE Cyberonics, Inc.

Latest Press Release on General News

Precision oncology company Flindr Therapeutics announces €20 million Series A financing to advance first-in-class small molecule inhibitors

V-Bio Ventures leads international syndicate which includes Johnson & Johnson Innovation – JJDC, Inc., QBIC Fund, Flanders Future Tech Fund, Curie Capital as well as seed investor...

Rett Syndrome Research Trust Partners with Vivalink to Shift Symptom Assessment Paradigms in Rett Syndrome

Vivalink's remote patient monitoring solutions accelerate research into rare neurological disorder CAMPBELL, Calif. , April 23, 2024 /PRNewswire/ -- Vivalink , a leading pro...

World IBS Day - April 19th: Raising Awareness for Everyone with IBS

Debunking myths about Irritable Bowel Syndrome TORONTO , April 18, 2024 /PRNewswire/ -- IBS is a chronic gastrointestinal disorder with symptoms like abdominal pain, bloating,...

Important step taken on the Canada Disability Benefit in Budget 2024, but funding falls short

More work must be done to lift Canadians with disabilities out of poverty TORONTO , April 17, 2024 /CNW/ - The federal government has taken an important step on the Canada Di...

Hydrinity Accelerated Skin Science Introduces MicroFusion Technology and Expands Facial Skincare Line with PRELUDE Facial Treatment Cleanser and HYDRI-C Vitamin C Moisturizer

The Next Generation Technology with the Power to Transform Skin MONROE, La. , April 15, 2024 /PRNewswire/ -- Hydrinity Accelerated Skin Science announced today the launch of t...